We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Blood Test Measures Repetitive DNA for Early Cancer Detection

By LabMedica International staff writers
Posted on 05 Mar 2024
Print article
Image: The machine learning model detects a small, previously overlooked family of repetitive DNA (Photo courtesy of 123RF)
Image: The machine learning model detects a small, previously overlooked family of repetitive DNA (Photo courtesy of 123RF)

Cancer patients can have varying levels of a specific kind of repetitive DNA known as Alu elements in comparison to those without cancer. Despite constituting about 11% of the DNA in humans and other primates, Alu elements have traditionally been considered too complex to be effectively utilized as biomarkers due to their small, repetitive nature. Now, advancements in machine learning can allow for the measurement of these elements through a simple blood draw.

Researchers at Johns Hopkins Medicine (Baltimore, MD, USA) leveraged this insight to improve a test designed for early cancer detection. They began their study with a sample size that was ten times larger than what is usually seen in such research. Alu elements are relatively small, each being about 300 base pairs in length within the vast 2 billion-step DNA ladder. Yet, changes in the proportion of Alu elements in blood plasma are consistent, irrespective of the cancer’s origin. The research team had previously developed a test for detecting aneuploidy, a condition involving chromosome copy number alterations common in cancers, using a liquid biopsy blood test. This test identifies fragments of cancer cell DNA circulating in the bloodstream. While conducting this research, they noticed an unusual signal that differentiated between cancer and non-cancer, which wasn’t attributed to changes in chromosome numbers. Consequently, they combined their original test, which analyzed 350,000 repetitive DNA locations, with an unbiased machine learning approach.

In their study, the team analyzed samples from 3,105 individuals with solid tumors and 2,073 without cancer, covering 11 types of cancer and evaluating 7,615 blood samples. The repetitive DNA sequences were examined repeatedly to assess the accuracy of the model. They achieved a specificity rate of 98.9%, crucial for minimizing false positives, especially when screening asymptomatic individuals to avoid erroneous cancer diagnoses. In an independent validation set, incorporating Alu elements into the machine learning model identified 41% of cancer cases that were missed by eight existing biomarkers and the team’s earlier test. The most significant contributor to cancer detection was identified as AluS, the largest subfamily of Alu elements. People with cancer were found to have lower levels of AluS in their blood plasma than typical. The researchers expect their Alu-based cancer detection method to complement the array of existing cancer diagnostic tools. Their next step involves identifying the most promising biomarkers and combining them for enhanced efficacy.

Related Links:
Johns Hopkins Medicine

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)
New
H-FABP Test
Finecare H-FABP Rapid Quantitative Test
New
Borrelia Burgdorferi Test
AESKULISA Borrelia-M

Print article

Channels

Microbiology

view channel
Image

POC PCR Test Rapidly Detects Bacterial Meningitis Directly at Point of Sample Collection

Meningitis is an inflammation of the membranes surrounding the brain and spinal cord. Pathogens typically enter the body through the respiratory tract and spread via the bloodstream. The infection can... Read more

Pathology

view channel
Image: The unique AI tool predicts cancer prognoses and responses to treatment (Photo courtesy of Shutterstock)

AI Tool Combines Data from Medical Images with Text to Predict Cancer Prognoses

The integration of visual data (such as microscopic and X-ray images, CT and MRI scans) with textual information (like exam notes and communications between doctors of different specialties) is a crucial... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The investment is in line with Danaher’s aim to accelerate the transition to precision medicine with AI-enabled diagnostics

Danaher Partners with Healthcare AI Company Innovaccer on Novel Digital and Diagnostic Solutions

Danaher Diagnostics LLC and Danaher Ventures LLC, two subsidiaries of Danaher Corporation (Washington, DC, USA), has formed an investment partnership with healthcare artificial intelligence (AI) company... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.